Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
141.18
-0.01 (-0.01%)
May 8, 2026, 3:00 PM CST
SHA:600436 Revenue
Zhangzhou Pientzehuang Pharmaceutical., had revenue of 2.74B CNY in the quarter ending March 31, 2026, a decrease of -12.74%. This brings the company's revenue in the last twelve months to 8.60B, down -20.05% year-over-year. In the year 2025, Zhangzhou Pientzehuang Pharmaceutical., had annual revenue of 9.00B, down -16.56%.
Revenue (ttm)
8.60B
Revenue Growth
-20.05%
P/S Ratio
9.90
Revenue / Employee
2.98M
Employees
2,839
Market Cap
85.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.00B | -1.79B | -16.56% |
| Dec 31, 2024 | 10.79B | 729.37M | 7.25% |
| Dec 31, 2023 | 10.06B | 1.36B | 15.69% |
| Dec 31, 2022 | 8.69B | 672.45M | 8.38% |
| Dec 31, 2021 | 8.02B | 1.51B | 23.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 54.56B |
| Sichuan Kelun Pharmaceutical | 18.38B |
| Yifan Pharmaceutical | 5.06B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 3.11B |
| GuangYuYuan Chinese Herbal Medicine | 1.44B |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.09B |
| Shanghai InnoStar Bio-tech | 812.23M |
| Chongqing Lummy Pharmaceutical | 759.50M |